These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 23355687)
1. Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips. Mackie SL; Pease CT Postgrad Med J; 2013 May; 89(1051):284-92. PubMed ID: 23355687 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis. Matteson EL; Buttgereit F; Dejaco C; Dasgupta B Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552 [TBL] [Abstract][Full Text] [Related]
3. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis. Pioro MH Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126 [TBL] [Abstract][Full Text] [Related]
4. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. Buttgereit F; Dejaco C; Matteson EL; Dasgupta B JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619 [TBL] [Abstract][Full Text] [Related]
5. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy]. Becker M Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763 [TBL] [Abstract][Full Text] [Related]
6. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis. Mansalis K FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832 [TBL] [Abstract][Full Text] [Related]
7. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database. Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397 [TBL] [Abstract][Full Text] [Related]
8. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice. Lally L; Spiera R Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056 [TBL] [Abstract][Full Text] [Related]
9. Giant cell arteritis and polymyalgia rheumatica: an update. González-Gay MA; Pina T Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572 [TBL] [Abstract][Full Text] [Related]
10. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica. El Chami S; Springer JM Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374 [TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management. Schmidt J; Warrington KJ Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500 [TBL] [Abstract][Full Text] [Related]
12. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis. Man-Ger Sun M; Pope JE Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101822. PubMed ID: 36907732 [TBL] [Abstract][Full Text] [Related]
13. [Polymyalgia rheumatica and temporal arteritis]. Vos PA; Bijlsma JW; Derksen RH Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1932-7. PubMed ID: 16159030 [TBL] [Abstract][Full Text] [Related]
14. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica. Camellino D; Matteson EL; Buttgereit F; Dejaco C Nat Rev Rheumatol; 2020 Sep; 16(9):481-495. PubMed ID: 32759996 [TBL] [Abstract][Full Text] [Related]
15. Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis. Muratore F; Pipitone N; Hunder GG; Salvarani C Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S86-92. PubMed ID: 24129145 [TBL] [Abstract][Full Text] [Related]